| |
| |
|
| Insider
Information: |
Golumbeski George |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
62,613 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,613 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
Director |
2019-03-04 |
0 |
2019-02-11 |
0 |
Premium* |
|
|
Shattuck Labs, Inc. |
STTK |
Director |
2022-04-26 |
54,613 |
2022-04-21 |
0 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2022-05-05 |
8,000 |
2022-05-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2022-05-05 |
4 |
B |
$31.45 |
$251,563 |
D/D |
8,000 |
8,000 |
0.01 |
- |
|
| STTK |
Shattuck Labs, Inc. |
Director |
– • – |
2022-04-26 |
4 |
B |
$3.63 |
$102,838 |
D/D |
28,330 |
54,613 |
2.39 |
- |
|
| STTK |
Shattuck Labs, Inc. |
Director |
– • – |
2022-04-22 |
4 |
B |
$3.67 |
$859 |
D/D |
234 |
26,283 |
2.31 |
- |
|
| STTK |
Shattuck Labs, Inc. |
Director |
– • – |
2022-04-21 |
4 |
B |
$3.69 |
$96,121 |
D/D |
26,049 |
26,049 |
2.39 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-03-04 |
4 |
AS |
$103.65 |
$961,897 |
D/D |
(9,280) |
0 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-03-04 |
4 |
OE |
$36.61 |
$339,741 |
D/D |
9,280 |
9,280 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-02-12 |
4 |
AS |
$90.07 |
$1,011,301 |
D/D |
(11,228) |
0 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-02-12 |
4 |
OE |
$25.58 |
$313,012 |
D/D |
11,228 |
11,228 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-02-11 |
4 |
AS |
$90.03 |
$204,552 |
D/D |
(2,272) |
0 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
Director |
– • – |
2019-02-11 |
4 |
OE |
$25.58 |
$58,118 |
D/D |
2,272 |
2,272 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
